The Research and Development Scientists at Solve Therapeutics, Inc. focus on the discovery and optimization of innovative antibody drug conjugates and bispecific therapeutics. This team conducts cutting-edge research in drug design, conducts preclinical studies, and collaborates across disciplines to drive the development of targeted cancer therapies. Their goal is to advance promising candidates from initial discovery through to clinical evaluation, ultimately improving treatment options for patients with cancer.
View all